Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Intravitreal Ranibizumab Injection on Aqueous Humor Concentrations of Vascular Endothelial Growth Factor and Pigment Epithelium-derived Factor in Patients With Myopic Choroidal Neovascularization.

NCT02175940 is registered in ClinicalTrials.gov with Università degli Studi di Brescia as lead sponsor.

NCT NCT02175940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02175940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Intravitreal Ranibizumab Injection on Aqueous Humor Concentrations of Vascular Endothelial Growth Factor and Pigment Epithelium-derived Factor in Patients With Myopic Choroidal Neovascularization.
Lead sponsor
Università degli Studi di Brescia
Phase
Observational
Overall status
Completed
Start date
July 31, 2013
Completion date
May 31, 2014
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myopic choroidal neovascularization, pedf aqueous level, vegf aqueous level